334 related articles for article (PubMed ID: 31712357)
1. Impact of brand drug discount cards on private insurer, government and patient expenditures.
Law MR; Chan FKI; Harrison M; Worthington HC
CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
[TBL] [Abstract][Full Text] [Related]
2. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
3. Private expenditures on brand name prescription drugs after generic entry.
Balaban DY; Dhalla IA; Law MR; Bell CM
Appl Health Econ Health Policy; 2013 Oct; 11(5):523-9. PubMed ID: 23979876
[TBL] [Abstract][Full Text] [Related]
4. Prescription drug costs and the generic dispensing ratio.
Liberman JN; Roebuck MC
J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
[TBL] [Abstract][Full Text] [Related]
5. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
6. Association Between Prescription Drug Discount Cards and Out-of-Pocket Costs for HFrEF Regimens.
Wheeler JS; Heidel RE; Dong A; Pleines KM; Hauptman PJ
Circ Cardiovasc Qual Outcomes; 2023 Oct; 16(10):e009987. PubMed ID: 37847754
[TBL] [Abstract][Full Text] [Related]
7. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
8. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
Wineinger NE; Zhang Y; Topol EJ
JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
[TBL] [Abstract][Full Text] [Related]
9. Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.
Morgan SG; Li W; Yau B; Persaud N
CMAJ; 2017 Feb; 189(8):E295-E302. PubMed ID: 28246223
[TBL] [Abstract][Full Text] [Related]
10. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
Yeung K; Dusetzina SB; Basu A
JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
[TBL] [Abstract][Full Text] [Related]
11. Drug discount cards in an era of higher prescription drug prices: A retrospective population-based study.
Munigala S; Brandon M; Goff ZD; Sagall R; Hauptman PJ
J Am Pharm Assoc (2003); 2019; 59(6):804-808.e1. PubMed ID: 31422026
[TBL] [Abstract][Full Text] [Related]
12. Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.
Fischer MA; Avorn J
Health Serv Res; 2003 Aug; 38(4):1051-63. PubMed ID: 12968816
[TBL] [Abstract][Full Text] [Related]
13. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
Tseng CW; Brook RH; Keeler E; Mangione CM
JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
[TBL] [Abstract][Full Text] [Related]
14. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
15. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
16. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
Cheng N; Banerjee T; Qian J; Hansen RA
J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
[TBL] [Abstract][Full Text] [Related]
17. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
[TBL] [Abstract][Full Text] [Related]
18. Medicare-approved drug discount cards and renal transplant patients: how much can these cards reduce prescription costs?
Chisholm MA; Marshall J; Smith KE; Garrett CJ; Turner JC
Clin Transplant; 2005 Jun; 19(3):357-63. PubMed ID: 15877798
[TBL] [Abstract][Full Text] [Related]
19. Savings from drug discount cards: relief for Medicare beneficiaries?
Cubanski J; Frank RG; Epstein AM
Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-198-209. PubMed ID: 15451980
[TBL] [Abstract][Full Text] [Related]
20. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
